Each year, at least 500,000 people experience venous ulcers, a chronic, non-healing wound that results from inadequate blood flow to the affected area, often on a person’s leg. This condition causes severe pain and represents the largest group of chronic wound healing disorders.
Current treatment options
Current treatments for venous ulcers involve compression therapies, escalating to more complex and expensive therapies. Many such chronic wounds display limited capacity for healing and a high degree of inflammation.
Local administration of ADRCs demonstrated the potential to jump-start the healing process and reduce pain. The FDA has given its approval to proceed with a feasibility study.
Clinical Trial Status